Microbial and cancer cell membranes

Microbial and cancer cell membranes represent a unique class of therapeutic targets characterized by their distinct lipid composition compared to healthy mammalian cells. While normal eukaryotic membranes are predominantly zwitterionic, both microbial and neoplastic cell membranes often display a high density of anionic (negatively charged) components on their outer leaflets, such as phosphatidylglycerol (PG) and cardiolipin (CL) in bacteria, or phosphatidylserine (PS) and glycosylated mucins in cancer cells [1, 2]. This fundamental biochemical difference allows for the selective targeting by cationic host defense peptides and synthetic membrane-active agents through electrostatic attraction [3]. Upon binding, these agents disrupt the membrane's structural integrity via mechanisms such as pore formation (e.g., barrel-stave or toroidal models) or a detergent-like carpet effect, leading to rapid cytoplasmic leakage and cell death [4, 5]. Because these drugs target the physical structure of the membrane rather than specific protein receptors, they are generally less susceptible to traditional molecular resistance mechanisms, making them promising candidates for treating multidrug-resistant infections and malignancies [1, 4].

Other names

Bacterial cell membranesNeoplastic cell membranesAnionic lipid bilayersCytoplasmic membranesPlasma membranes

Drugs targeting these membranes typically utilize electrostatic interactions between cationic molecules and anionic membrane components (e.g., phosphatidylserine or phosphatidylglycerol) to induce membrane permeabilization, pore formation (barrel-stave, toroidal, or aggregate models), or physical disruption (carpet/detergent-like effect), leading to cytoplasmic leakage and cell death.